Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-06-20
1992-06-02
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Lymphokine
4352351, 435236, 435237, 435239, 4352401, 435245, A61K 3912, C12N 700
Patent
active
051185024
ABSTRACT:
A Newcastle disease vaccine and method of using the vaccine for protecting a poultry animal from Newcastle disease is provided. The vaccine consists of a naturally attenuated live Newcastle disease virus which has the identifying characteristics of ATCC No. VR 2239. The vaccine is capable of conferring solid immunity against Newcastle disease and causes minimal respiratory or other undesirable reactions in inoculated animals.
REFERENCES:
patent: 4235876 (1980-11-01), Gits et al.
patent: 4279893 (1981-07-01), Kreimer et al.
Newcastle Disease in Poultry: a New Food Pellet Vaccine, Australian Centre for International Agricultural Research, Canberra, 1987, John W. Copland, Ed.
Borland et al., Biological Abstracts, vol. 71 (1), Reference #2874, 1980.
Copland, Newcastle Disease in Poultry, a New Food Pellet Vaccine, Australian Center for International Agricultural Research, Canberra, 1987.
Glisson John R.
Villegas Pedro
Brown Johnnie R.
Mohamed Abdel A.
The University of Georgia Research Foundation Inc.
LandOfFree
Naturally attenuated Newcastle disease vaccine and method of usi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naturally attenuated Newcastle disease vaccine and method of usi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naturally attenuated Newcastle disease vaccine and method of usi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2227230